North America Dominates Breast Cancer Liquid Biopsy Market in 2024
The breast cancer liquid biopsy market is undergoing a transformative shift in cancer diagnostics. Valued at USD 1.13 billion in 2023, this dynamic market is projected to reach USD 2.37…